LENEXA, Kan., Nov. 6, 2006 (PRIMEZONE) -- Mediware Information Systems (Nasdaq:MEDW) announced that Lee Memorial Health System, a community-owned healthcare system comprised of four medical facilities in Florida, licensed Mediware's HCLL(tm) Transfusion and LifeTrak(r) Blood Management software products for its southwest Florida area facilities. Lee Memorial Health System is governed by a publicly elected board of directors whose members oversee every aspect of its operation. The four facilities included in this license agreement include:
-- Lee Memorial Hospital in Fort Myers, Fla. is 367-bed acute care
facility providing services throughout Lee County and its
surrounding communities. Like the other providers of Lee Memorial
Health System, Lee Memorial Hospital has been recognized as one
of the 100 Top Hospitals, specifically for strokes, orthopedics
and intensive care.
-- HealthPark Medical Center in Fort Myers, Fla. recently expanded
its operations to 360 beds. The medical center has received
recognition as a 100 Top Hospitals for cardiology and intensive
care.
-- The Children's Hospital of Southwest Florida, also located in
Fort Myers, Fla., is a pediatric specialty hospital that was
established in 1992 to meet the growing needs of southwest
Florida. It is the only comprehensive child healthcare facility
between Tampa and Miami.
-- Cape Coral Hospital, situated in Cape Coral, Fla., is an acute
care facility that has grown from 94 beds to its present operation
of 281 beds. Cape Coral Hospital has the area's largest emergency
department and is recognized by the 100 Top Hospitals for
orthopedic care.
"Mediware is very pleased to provide its next-generation Blood Management products to Lee Memorial to address the diversity and complexity of their operations," said John Damgaard, vice president and general manager of Mediware's Blood Management Division. "We look forward to our partnership and supporting their commitment to patient care excellence."
HCLL(tm) Transfusion software, Mediware's next-generation transfusion management system, was designed to manage blood products administered to patients at hospitals and centralized transfusion service facilities. The product is used to address all phases of transfusion service activities.
LifeTrak(r), Mediware's blood center blood donor management software, is used to address all phases of blood center activities in a freestanding environment as well as in a hospital-based facility. The product provides comprehensive donor identification, donor eligibility, collections data tracking system, marketing, campaign, and drive analysis. It is used to manage and process controls from the recruitment of blood donors to the ultimate delivery of blood products to health care facilities.
About Mediware
Mediware delivers powerful software solutions that encapsulate patient care instructions, reinforce patient safety practices and improve efficiencies to lower costs. Mediware targets three primary areas of patient care -- Medication Management, Perioperative management and Blood transfusion, inventory and donor practices -- with specialized solutions that are proven in more than 1,000 client installations. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at www.mediware.com.
Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2006, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.